REP 3123: Clinical Trials

3 trials of REP 3123, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow REP 3123: new trials by email Literature Review of REP 3123 trials Research Report on REP 3123

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants
CRS3123 200 mg capsule - Food Effect in Healthy Participants
Phase 1CompletedCrestone, Inc172025-04-212026-03-18
Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.
Placebo, CRS3123 - Clostridium Difficile Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362014-06-012016-06-13
Phase I Trial of a Single Dose of CRS3123
CRS3123, Placebo - Clostridium Difficile Colitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)402012-05-222017-09-25

Conditions studied

Clostridium Infections (1)  ·  Enterocolitis, Pseudomembranous (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Crestone, Inc (1)

Countries

United States (3)

Results publications

PMID 28584140, PMID 31685472